Get started
Author

Diego Alejandro Dri

Observed name: D.A. Dri
ORCID: 0000-0002-5110-3582
Observed ORCID: 0000-0002-5110-3582
OpenAlex ID: A5049284882
The preparation of quaternary ammonium-based ionic liquid containing a cyano group and its properties in a lithium battery electrolyte
2004 · Minato Egashira, Shigeto Okada, et al. · Journal of Power Sources · 121
Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes
2022 · Diego Alejandro Dri, Federica Rinaldi, et al. · Drug Delivery and Translational Research · 97
PDF
Regulatory Considerations on the use of Machine Learning based tools in Clinical Trials
2022 · Maurizio Massella, Diego Alejandro Dri, et al. · Health and Technology · 25
PDF
Surfactants, Nanomedicines and Nanocarriers: A Critical Evaluation on Clinical Trials
2021 · Diego Alejandro Dri, Carlotta Marianecci, et al. · Pharmaceutics · 22
PDF
Clinical Trials and Machine Learning: Regulatory Approach Review
2021 · Diego Alejandro Dri, Maurizio Massella, et al. · Reviews on Recent Clinical Trials · 7
Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office
2022 · Diego Alejandro Dri, Elisa Gaucci, et al. · Pharmaceutics · 6
PDF
Rosmarinic acid based nasal spray formulation: Comparative study of nanoemulsions vs solid lipid nanoparticles
2026 · Maria Gioia Fabiano, Francesca Romana Stacchini, et al. · International Journal of Pharmaceutics · 3
Tracking a decade of phase I clinical trials in Italy: trends and insights from national and european registries amid regulatory change
2025 · Eleonora De Paola, Luna Del Bono, et al. · Frontiers in Pharmacology · 2
PDF
Quality Assessment of Investigational Medicinal Products in COVID-19 Clinical Trials: One Year of Activity at the Clinical Trials Office
2021 · Diego Alejandro Dri, Giulia Praticò, et al. · Pharmaceuticals · 2
PDF
Horizon scanning to shape nanomedicines through researcher–regulator collaboration
2025 · Yoana Nuevo, Eva Hemmrich, et al. · Nature Reviews Materials · 1
Critical Analysis of Non-profit Clinical Trials: Three Years of Activity at the Clinical Trials Office
2025 · Diego Alejandro Dri, Marta De Cata, et al. · Reviews on Recent Clinical Trials · 1
PDF
Rare disease clinical trials in Italy (2022–May 2026): current trends, future challenges, and the evolving role as reporting member state
2026 · Eleonora De Paola, Fabrizio Galliccia, et al. · Frontiers in Pharmacology
A decade of clinical trials in Italy (2016–2025): trends, regulatory transformation and biotechnological evolution
2026 · Eleonora De Paola, Diego Alejandro Dri, et al. · Frontiers in Pharmacology
PDF
Ethics Committees Selection in Italy under EU Regulation 536/2014: A Three-year Governance Analysis
2026 · Giulia Pierfelice, Eleonora De Paola, et al. · Reviews on Recent Clinical Trials
Contributors
2024 · N. Aguiam, Zeeshan Ahmed, et al. · Elsevier eBooks
The role of artificial intelligence and machine learning in clinical trials
2024 · D.A. Dri, M. Massella, et al. · Elsevier eBooks
Works count: 17
Citation count: 287
H-index: 6
I10-index: 4
Year
Topic
Type